Healthcare • Biotechnology
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MDWD is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
13 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 43 days ago
Red flags: 0
79 filers reported a long position in MDWD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| INVESTOR AB | $12.8M | 872.1K | Unchanged |
| Yelin Lapidot Holdings Management Ltd. | $11.1M | 758.2K | -0.6% |
| Rosalind Advisors, Inc. | $11M | 749.1K | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ | $9.4M | 641.1K | -9.7% |
| BlackRock, Inc. | $7.7M | 525.9K | +18% |
| SPHERA FUNDS MANAGEMENT LTD. | $4M | 273.2K | Unchanged |
| Silverberg Bernstein Capital Management LLC | $3.4M | 228.1K | +14.1% |
| STATE STREET CORP | $2.5M | 168.7K | +17.3% |
| UBS Group AG | $2.3M | 155.9K | -2.4% |
| GEODE CAPITAL MANAGEMENT, LLC | $2.1M | 141K | +15.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.